View in EDS

617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study.

Saved in:
Bibliographic Details
Title: 617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study.
Authors: Simonelli, M.1 (AUTHOR), Lorusso, D.2 (AUTHOR), Homicsko, K.3 (AUTHOR), Seguy, F.4 (AUTHOR), Kinder, M.5 (AUTHOR), Liu, Q.6 (AUTHOR), Croft, E.7 (AUTHOR), Kitano, S.8 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS495-S495. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179692082
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Simonelli%2C+M%2E%22">Simonelli, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Homicsko%2C+K%2E%22">Homicsko, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seguy%2C+F%2E%22">Seguy, F.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kinder%2C+M%2E%22">Kinder, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Q%2E%22">Liu, Q.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Croft%2C+E%2E%22">Croft, E.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kitano%2C+S%2E%22">Kitano, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS495-S495. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692082
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.684
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S495
    Titles:
      – TitleFull: 617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Simonelli, M.
      – PersonEntity:
          Name:
            NameFull: Lorusso, D.
      – PersonEntity:
          Name:
            NameFull: Homicsko, K.
      – PersonEntity:
          Name:
            NameFull: Seguy, F.
      – PersonEntity:
          Name:
            NameFull: Kinder, M.
      – PersonEntity:
          Name:
            NameFull: Liu, Q.
      – PersonEntity:
          Name:
            NameFull: Croft, E.
      – PersonEntity:
          Name:
            NameFull: Kitano, S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1